Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial
Meletios Athanasios Dimopoulos, Sagar Lonial, Keith A. Betts, Clara C. Chen, Miriam L. Zichlin, Alexander Brun and 6 more
- Rank
- 32 of 550
- Percentile
- top 5.9%
- Where
- Cancer, 2018
- Citations
- 141
From the 2018 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.